Cited by 186Blood Pressure and Hypertension StudiesCardiovascular Health and Disease PreventionSodium Intake and Health

Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure

Open access
on behalf of Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) investigators, Asayama, Kei, Ohkubo, Takayoshi, Metoki, Hirohito, Obara, Taku, Inoue, Ryusuke, Kikuya, Masahiro, Thijs, Lutgarde +2 more·2012·Hypertension Research

Abstract

Hypertension guidelines recommend blood pressure self-measurement at home (HBP), but no previous trial has assessed cardiovascular outcomes in hypertensive patients treated according to HBP. The multicenter Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP; 2001-2010) trial involved 3518 patients (50% women; mean age 59.6 years) with an untreated systolic/diastolic HBP of 135-179/85-119 mm Hg. In a 2 × 3 design, patients were randomized to usual control (125-134/80-84 mm Hg (UC)) vs. tight control (<125/<80 mm Hg (TC)) of HBP and to initiation of drug treatment with angiotensin converting enzyme inhibitors, angiotensin receptor blockers or calcium channel blockers. During follow-up, a computer algorithm automatically generated treatment recommendations based on HBP. At the last follow-up (median 5.3 years), TC patients used more antihypertensive drugs than UC patients (1.82 vs. 1.74 defined daily doses, P=0.045) and had a greater HBP reduction (21.3/13.1 mm Hg vs. 22.7/13.9 mm Hg, P=0.018/0.020), but they less frequently achieved the lower HBP targets (37.4 vs. 63.5%, P<0.0001). The primary end point, cardiovascular death plus stroke and myocardial infarction, occurred in 25 UC and 26 TC patients (hazard ratio, 1.02; 95% confidence interval, 0.59-1.77; P=0.94). Rates were similar (P≥0.13) in the three drug groups. In all patients combined, the risk of the primary end point independently increased by 41% (6-89%; P=0.019) and 47% (15-87%; P=0.0020) for a 1-s.d. increase in baseline (12.5 mm Hg) and follow-up (13.2 mm Hg) systolic HBP. The 5-year risk was minimal (≤1%) if on-treatment systolic HBP was 131.6 mm Hg or less. HOMED-BP proved the feasibility of adjusting antihypertensive drug treatment based on HBP and suggests that a systolic HBP level of 130 mm Hg should be an achievable and safe target.

Integrity signals

Registry

Crossref · 10.1038/hr.2012.125

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
on behalf of Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) investigators, Asayama, K., Ohkubo, T., Metoki, H., Obara, T., Inoue, R., Kikuya, M., Thijs, L., Staessen, J. A., & Imai, Y.
Affiliations
  • Tohoku University (JP)
  • Shiga University of Medical Science (JP)
  • Maastricht University (NL)
Corresponding author
Imai, Yutaka
Venue
Hypertension Research
Published
2012-08-16
Volume
35
Issue
11
Pages
1102-1110
ISSN
  • 0916-9636 (ISSN-L)
  • 1348-4214
OpenAlex
W2020243407
Cited by
186
References
47
Citations by year
2026: 12 · 2025: 16 · 2024: 8 · 2023: 6 · 2022: 16 · 2021: 17 · 2020: 11 · 2019: 19 · 2018: 20 · 2017: 16 · 2016: 16 · 2015: 10 · 2014: 7 · 2013: 8 · 2012: 4
FWCI
5.92
Type
journal article
Language
en
Open access
Locations
  • Hypertension Research (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Japan Cardiovascular Research Foundation
  • Omron Healthcare
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords
hypertension, self-measured blood pressure, antihypertensive therapy, cardiovascular outcomes, cardiovascular mortality, stroke, myocardial infarction, tight blood pressure control, ACE inhibitors, angiotensin receptor blockers, calcium channel blockers, systolic blood pressure, primary prevention, secondary prevention, cardiovascular risk prediction, antihypertensive medication use
MeSH terms
Algorithms, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Blood Pressure, Calcium Channel Blockers, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Hypertension, Male, Middle Aged, Prospective Studies, Risk Factors, Treatment Outcome, Blood Pressure Monitoring, Ambulatory, Angiotensin II Type 1 Receptor Blockers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review